APA (7th ed.) Citation

Kotrbová, V., Mrázová, B., Moserová, M., Martínek, V., Hodek, P., Hudeček, J., . . . Stiborová, M. (2011). Cytochrome b5 shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy. Biochemical pharmacology, 82(6), . https://doi.org/10.1016/j.bcp.2011.06.003

Chicago Style (17th ed.) Citation

Kotrbová, Věra, Barbora Mrázová, Michaela Moserová, Václav Martínek, Petr Hodek, Jiří Hudeček, Eva Frei, and Marie Stiborová. "Cytochrome B5 Shifts Oxidation of the Anticancer Drug Ellipticine by Cytochromes P450 1A1 and 1A2 from Its Detoxication to Activation, Thereby Modulating Its Pharmacological Efficacy." Biochemical Pharmacology 82, no. 6 (2011). https://doi.org/10.1016/j.bcp.2011.06.003.

MLA (9th ed.) Citation

Kotrbová, Věra, et al. "Cytochrome B5 Shifts Oxidation of the Anticancer Drug Ellipticine by Cytochromes P450 1A1 and 1A2 from Its Detoxication to Activation, Thereby Modulating Its Pharmacological Efficacy." Biochemical Pharmacology, vol. 82, no. 6, 2011, https://doi.org/10.1016/j.bcp.2011.06.003.